Monday, June 15, 2026

Police Crack Down on Major Sex Trade Hub in Gwangju’s Tech District

A business owner who operated an unauthorized...

Landing Giants: How Aircraft Tires Handle Extreme Conditions

Known as a jumbo jet, Boeing's B747...

OpenAI Adopts Anthropic’s Universal Translator for AI Models

OpenAI's adoption of Anthropic's Model Context Protocol marks a strategic shift towards open-source integration across its products.

Tag: drugs

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Teen Prescriptions for GLP-1 Obesity Drugs Surge in Korea, Raising Misuse Concerns

Surge in GLP-1 obesity treatment prescriptions among teens raises concerns over misuse and potential health risks.

Mounjaro prescriptions surge 12-fold in 8 months, surpassing 200,000 monthly for the first time

Mounjaro prescriptions surged over tenfold in eight months, raising concerns about access for patients with obesity amid rising cosmetic demand.

44 Billion Won Drug Smuggling Case: How a Telegram Network Operated Illegal Pharmaceutical Sales

A South Korean drug gang has been indicted for selling $33 million in illegal pharmaceuticals, using messaging apps for distribution.

Samchundang Pharma CEO Claims FDA Recognition for Obesity Drug as Generic

Samchundang Pharma's CEO announces FDA recognition of oral semaglutide as a generic and withdraws $1.7 billion stock sale plan.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

How Long-Term Use of Anticholinergic Medications Increases Fracture Risk by 65% in Seniors

A study reveals older adults on long-term medications face a 43% higher fracture risk, emphasizing the danger of anticholinergic drugs.

NovaCell Technology Passes KOSDAQ Evaluation: What This Means for DongKoo BioPharm’s Future

Donggu Bio Pharmaceutical announces that its invested company, Novacell Technologies, has passed the technical evaluation for KOSDAQ listing.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Will Novo Nordisk’s 50% Price Cut on Wegovy Spark a Price War in Korea’s Obesity Drug Market?

Novo Nordisk's price cuts for GLP-1 obesity treatments in the U.S. may influence South Korean market dynamics, though immediate effects seem limited.

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

K-Bio Revolution: How Korean Biopharmaceuticals Are Conquering the Global Market in 2026

South Korea's pharmaceutical industry thrives with innovative drugs like botulinum toxins and cancer treatments, targeting global markets.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

ProGen’s PG-110 Targets Fat Loss Without Muscle Waste—Next-Gen Obesity Drug in Focus

ProGen will present non-clinical results of its obesity drug PG-110 at the ADA conference, targeting muscle preservation and weight loss.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.